CompositionRybelsus 3 mg Tablet is used to treat type 2 diabetes mellitus to achieve stable blood glucose levels in adults. It helps improve blood sugar control, including after meals, and may reduce cardiovascular risk in appropriate patients. This oral medicine provides an alternative to injectable GLP-1 receptor agonists.
This medication contains Semaglutide as its active ingredient, operating as a potent glucagon-like peptide-1 (GLP-1) receptor agonist. It works by triggering natural insulin secretion during elevated blood sugar states, decreasing hepatic glucose output, and delaying gastric emptying. This helps control blood sugar, reduces appetite, and supports weight management.
This tablet must be swallowed whole on an empty stomach with a small sip of water, at least 30 minutes before eating. Strictly following the exact dosage recommended by your healthcare provider is key to ensuring proper drug absorption and therapeutic effect. Always consult your doctor before starting therapy if you have a history of pancreatic or thyroid conditions.
